Drug shortage
Amphetamine Aspartate Monohydrate · Teva Pharmaceuticals USA, Inc.
FDA drug shortage · Current · updated Apr 7, 2025
Key facts
| Generic name | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet |
|---|---|
| Proprietary name | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate And Amphetamine Sulfate Tablets |
| Company | Teva Pharmaceuticals USA, Inc. |
| Presentation | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02) |
| Dosage form | Tablet |
| Strength | 1.875 mg |
| Status | Current |
| Therapeutic category | Psychiatry |
| Package NDCs | 0555-0775-02 |
| First posted | Oct 12, 2022 |
| Last updated | Apr 7, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: